President Obama’s budget for the 2012 fiscal year (FY) makes needed investments to strengthen key U.S. public health and research initiatives, in addition to strengthening the country’s capacity to prevent, diagnose, and treat an increasing number of ID threats, according to IDSA’s analysis. However, cuts proposed by the House of Representatives for the remainder of FY2011 would threaten these important gains in public health.
Released in February, the president’s budget supports critically needed ID research at the National Institutes of Health (NIH), especially at the National Institute for Allergy and Infectious Diseases (NIAID), according to an IDSA statement in response to the budget. An analysis published earlier this month in the New England Journal of Medicine underscores the important benefits this funding has on improving public health.
The president’s proposal includes investments for critical ID programs at the Centers for Disease Control and Prevention (CDC) and for the Food and Drug Administration (FDA)’s much-needed regulatory science and countermeasures initiatives. The Society also welcomed $765 million proposed for the Biomedical Advanced Research and Development Authority (BARDA), including funding to provide financial and business support to companies that develop new antibiotics and other medical countermeasures.
These critical investments in public health would be undercut by shortsighted spending cuts for the remainder of FY2011 proposed in February by lawmakers in the House.
In a joint statement, IDSA, the HIV Medicine Association (HIVMA), and the Center for Global Health Policy highlighted the danger to public health here and around the world posed by the drastic proposed cuts in critical funding for CDC, NIH, FDA, the Health Resources and Services Administration, the United States Agency for International Development, and other agencies. In an e-mail, IDSA also urged members to contact their members of Congress to communicate the value of funding ID and HIV-related research and public health programs and the dire consequences of these cuts.
For additional information about the president’s funding proposals for domestic HIV/AIDS funding and global HIV and tuberculosis, please see press releases issued by HIVMA and the Center for Global Health Policy (PDF).
< Previous Article | Next Article >